Boston Scientific Corp (BSX) reports impressive Q4 2024 results with 22.4% revenue growth and a 26% increase in adjusted EPS, ...

The Boston College Eagles (10-11, 2-8 ACC) men’s basketball team finishes a two-game home stand with a game against the ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

CEO Michael Mahoney highlighted the company’s exceptional performance in 2024, with operational sales growth of 23% in Q4 and 18.5% for the full year. Organic sales grew 20% in Q4, exceeding guidance.

I get to go skiing, wax poetic and spend hours pondering my beloved sport – and call it work. I also get to not only have opinions, but share them. WIth that, my ...

Cleveland's recent 112-105 defeat at the hands of the Boston Celtics on Tuesday night could have given their general manager ...

Charlie McAvoy got his 299th career point with a goal in the second period and Jeremy Swayman stopped 35 shots for his third ...

Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.

Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024 ...

A powerful winter storm has millions of people across at least 22 states from the Midwest to the Northeast on alert for a ...

Boston Scientific Corporation reported robust financial results in Q4 2024, with net sales reaching $4.561 billion, a 22.4% increase from the previous year.